Chronic kidney disease in acute coronary syndromes: real-world data of long-term outcomes
Related Experiment Video
Updated: Nov 8, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Carolina Saleiro1, Luís Puga1, Diana De Campos1
1Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Insights
Patients with chronic kidney disease (CKD) face higher cardiovascular risks. This study found comorbidities, not kidney function, predict survival after acute coronary syndrome.
Area of Science:
- Cardiology
- Nephrology
- Epidemiology
Background:
- Patients with chronic kidney disease (CKD) exhibit elevated cardiovascular risk.
- Acute coronary syndrome (ACS) in CKD patients requires careful prognostic evaluation.
Purpose of the Study:
- To investigate the association between CKD severity and outcomes following ACS.
- To identify predictors of all-cause mortality in ACS patients with varying degrees of renal function.
Main Methods:
- Retrospective cohort study of ACS patients categorized by CKD stages (3A, 3B, 4) using CKD-EPI and MDRD formulas.
- Primary endpoint: all-cause mortality, with a median follow-up of 32 months.
- Multivariable analysis adjusted for clinical factors.
Main Results:
- Decreased median survival correlated with poorer renal function in both CKD-EPI and MDRD groups (p < 0.014 and p < 0.006, respectively).
- Adjusted analysis revealed age and pulmonary artery systolic pressure as significant predictors of decreased survival (OR > 1.07).
- Estimated glomerular filtration rate (eGFR) was not independently associated with survival.
Conclusions:
- Comorbidities, specifically age and pulmonary artery systolic pressure, are more strongly associated with poor outcomes post-ACS than eGFR levels.
- CKD staging may not be the primary determinant of survival in ACS patients; focus on comorbidities is crucial.
Abstract:
Aim: Patients with chronic kidney disease (CKD) are at increased cardiovascular risk. Methods: Patients with acute coronary syndrome were retrospectively allocated to three groups (stage 3A, stage 3B or stage 4) based on the Kidney Disease Improving Global Outcomes classification formulas: the CKD Epidemiology Collaboration (CKD-EPI; N = 401) and the modification of diet in renal disease (n = 355). The primary end point was all-cause mortality (median follow-up time, 32 months [15-70]). Results: Study results showed decreased median survival was associated with poor renal function for both the CKD-EPI (78 vs 61 vs 40 months, p = 0.014) and modification of diet in renal disease groups (68 vs 57 vs 32 months, p = 0.006). After adjustment, age (OR: 1.07; 95% CI: 1.01-1.14) and pulmonary artery systolic pressure (OR: 1.08; 95% CI: 1.03-1.14), but not estimated glomerular filtration rate, were associated with decreased survival. Conclusion: Study results suggest that poor outcomes after an acute coronary syndrome were associated with comorbidities rather than estimated glomerular filtration rate level.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

